Adar1 Capital Management, LLC Eledon Pharmaceuticals, Inc. Transaction History
Adar1 Capital Management, LLC
- $500 Billion
- Q4 2024
A detailed history of Adar1 Capital Management, LLC transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 16,000 shares of ELDN stock, worth $71,520. This represents 0.01% of its overall portfolio holdings.
Number of Shares
16,000Holding current value
$71,520% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding ELDN
# of Institutions
62Shares Held
25.9MCall Options Held
0Put Options Held
0-
Bvf Inc San Francisco, CA6.29MShares$28.1 Million0.96% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$15.9 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.89MShares$12.9 Million0.0% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L32.55MShares$11.4 Million2.15% of portfolio
-
First Light Asset Management, LLC Edina, MN2.33MShares$10.4 Million0.93% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $61.5M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...